Technical Analysis for ANVS - Annovis Bio, Inc.

Grade Last Price % Change Price Change
B 10.545 3.89% 0.40
ANVS closed up 3.89 percent on Friday, January 22, 2021, on 1.14 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical ANVS trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Shooting Star Candlestick Bearish 3.89%
Lizard Bearish Bearish Day Trade Setup 3.89%
New 52 Week Closing High Bullish 3.89%
Pocket Pivot Bullish Swing Setup 3.89%
Older End-of-Day Signals for ANVS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 2 hours ago
Up 3% about 8 hours ago
Up 2% about 8 hours ago
Up 1% about 8 hours ago
2x Volume Pace about 8 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Mild Novi Amyloid Nervous System Neurodegeneration Psychiatric Diagnosis Alzheimer's Cognitive Disorders Neurodegenerative Disorders Cognitive Impairment Learning Disabilities Neuroprotection Gladstone Institutes Parkinson's Diseases

Is ANVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.2
52 Week Low 2.418
Average Volume 70,983
200-Day Moving Average 5.33
50-Day Moving Average 6.79
20-Day Moving Average 8.61
10-Day Moving Average 9.74
Average True Range 0.68
ADX 63.73
+DI 38.68
-DI 6.18
Chandelier Exit (Long, 3 ATRs ) 9.16
Chandelier Exit (Short, 3 ATRs ) 8.06
Upper Bollinger Band 11.30
Lower Bollinger Band 5.93
Percent B (%b) 0.86
BandWidth 62.37
MACD Line 1.07
MACD Signal Line 0.97
MACD Histogram 0.1038
Fundamentals Value
Market Cap 72.67 Million
Num Shares 6.89 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -64.85
Price-to-Sales 0.00
Price-to-Book 4.43
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.59
Resistance 3 (R3) 11.51 11.08 11.42
Resistance 2 (R2) 11.08 10.82 11.12 11.36
Resistance 1 (R1) 10.81 10.65 10.95 10.89 11.30
Pivot Point 10.39 10.39 10.45 10.43 10.39
Support 1 (S1) 10.12 10.12 10.25 10.20 9.79
Support 2 (S2) 9.69 9.96 9.73 9.73
Support 3 (S3) 9.42 9.69 9.67
Support 4 (S4) 9.50